CG Oncology CEO Buys Shares, Signals Confidence in Future Bladder‑Cancer Trials
CEO CG Oncology buy shows insider confidence amid rising Nasdaq shares—learn how option exercises and insider moves signal future value for investors.
3 minutes to read
CG Oncology Inc
CG Oncology Insider Trades Show Strategic Buy‑Low, Sell‑High Play by Director Mulay James
CG Oncology insider trades reveal Mulay James’ buy‑low/sell‑high strategy and large option stake, signaling confidence while managing liquidity and future upside.
4 minutes to read